2.20
price down icon5.98%   -0.14
after-market After Hours: 2.15 -0.05 -2.27%
loading
Collplant Biotechnologies Ltd stock is traded at $2.20, with a volume of 13,395. It is down -5.98% in the last 24 hours and down -19.12% over the past month. CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
See More
Previous Close:
$2.34
Open:
$2.35
24h Volume:
13,395
Relative Volume:
0.12
Market Cap:
$27.98M
Revenue:
$2.47M
Net Income/Loss:
$-13.87M
P/E Ratio:
-1.8033
EPS:
-1.22
Net Cash Flow:
$-12.42M
1W Performance:
-8.33%
1M Performance:
-19.12%
6M Performance:
-10.57%
1Y Performance:
-51.79%
1-Day Range:
Value
$2.20
$2.35
1-Week Range:
Value
$2.18
$2.4426
52-Week Range:
Value
$1.31
$4.99

Collplant Biotechnologies Ltd Stock (CLGN) Company Profile

Name
Name
Collplant Biotechnologies Ltd
Name
Phone
-
Name
Address
-
Name
Employee
57
Name
Twitter
@CollplantBio
Name
Next Earnings Date
2025-03-26
Name
Latest SEC Filings
Name
CLGN's Discussions on Twitter

Compare CLGN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CLGN
Collplant Biotechnologies Ltd
2.20 29.76M 2.47M -13.87M -12.42M -1.22
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.79 106.37B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.46 59.90B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.63 60.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
796.92 49.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.10 36.88B 4.56B -176.77M 225.30M -1.7177

Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-17-23 Initiated Alliance Global Partners Buy

Collplant Biotechnologies Ltd Stock (CLGN) Latest News

pulisher
Oct 12, 2025

Is CollPlant Biotechnologies Ltd. stock dividend yield sustainableTrade Signal Summary & Entry Point Strategy Guides - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

What drives CollPlant Biotechnologies Ltd CPT stock priceEnergy Sector Updates & Rapid Capital Gain - earlytimes.in

Oct 10, 2025
pulisher
Oct 10, 2025

Visualizing CollPlant Biotechnologies Ltd. stock with heatmapsEarnings Growth Summary & Short-Term High Return Strategies - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

CollPlant Biotechnologies Ltd. stock prediction for this weekJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Analyzing CollPlant Biotechnologies Ltd. with multi timeframe chartsQuarterly Growth Report & Capital Efficient Trade Techniques - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

CollPlant Biotechnologies (NASDAQ:CLGN) Trading Down 7.6% – What’s Next? - Defense World

Oct 08, 2025
pulisher
Oct 06, 2025

CollPlant Biotechnologies Ltd CPT Stock Analysis and ForecastMerger & Acquisition Updates & Market Trend Real-Time Reports - earlytimes.in

Oct 06, 2025
pulisher
Oct 06, 2025

Historical volatility pattern of CollPlant Biotechnologies Ltd. visualized2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Why CollPlant Biotechnologies Ltd. stock is trending among retail traders2025 Big Picture & Verified Entry Point Signals - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Quantitative breakdown of CollPlant Biotechnologies Ltd. recent moveTrend Reversal & Safe Entry Momentum Tips - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Multi factor analysis applied to CollPlant Biotechnologies Ltd.Earnings Summary Report & Entry Point Confirmation Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Tools to assess CollPlant Biotechnologies Ltd.’s risk profileWeekly Stock Summary & Community Driven Trade Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

How to manage a losing position in CollPlant Biotechnologies Ltd.Weekly Gains Summary & Fast Exit and Entry Trade Guides - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

One CollPlant Biotechnologies Insider Raised Their Stake In The Previous Year - Yahoo Finance

Oct 03, 2025
pulisher
Oct 03, 2025

Comparing CollPlant Biotechnologies Ltd. in custom built stock radarsWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Using data filters to optimize entry into CollPlant Biotechnologies Ltd.Portfolio Performance Summary & Community Trade Idea Sharing - newser.com

Oct 03, 2025
pulisher
Sep 30, 2025

Collplant stock plunges after advancing dermal filler to clinical trials By Investing.com - Investing.com Nigeria

Sep 30, 2025
pulisher
Sep 30, 2025

Collplant stock plunges after advancing dermal filler to clinical trials - Investing.com

Sep 30, 2025
pulisher
Sep 30, 2025

CollPlant advances photocurable dermal filler to clinical trials By Investing.com - Investing.com Australia

Sep 30, 2025
pulisher
Sep 30, 2025

CollPlant advances photocurable dermal filler to clinical trials - Investing.com India

Sep 30, 2025
pulisher
Sep 30, 2025

CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler - MarketScreener

Sep 30, 2025
pulisher
Sep 30, 2025

United States 3D Printed Organ Market Set to Transform - openPR.com

Sep 30, 2025

Collplant Biotechnologies Ltd Stock (CLGN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Cap:     |  Volume (24h):